Navigation Links
Breast Cancer Diagnostic and Drug Technologies: Global Markets
Date:8/28/2012

S IN PATIENTS WITH LYMPH NODES THAT

ARE POSITIVE FOR CANCER (%) 31

TABLE 13 FIVE-YEAR SURVIVAL RATES CORRELATED WITH TUMOR STAGE (%) 31

HER2 31

COMPANION DIAGNOSTICS 32

TARGETED THERAPIES 32

PREDICTIVE DIAGNOSTICS 32

TABLE 14 PREDICTIVE DIAGNOSTIC FEATURES 32

PREDICTIVE SAFETY BIOMARKERS 33

COMMERCIALIZED BIOMARKER TESTS 33

TABLE 15 CURRENT BIOMARKER TECHNOLOGIES 34

TABLE 16 BIOMARKER USES 35

BIOMARKERS AND DRUG THERAPY 35

INCREASED USE OF BIOMARKERS IN DRUG DEVELOPMENT AND CLINICAL TRIALS 36

OBSTACLES TO BIOMARKER DEVELOPMENT 36

TABLE 17 MAJOR ISSUES AND CHALLENGES 36

BIOMARKERS TYPES 37

PREDICTIVE BIOMARKERS 37

TUMOR INTERSTITIAL FLUID BIOMARKERS 37

PHARMACOGENOMIC BIOMARKERS IN DRUG LABELS 38

BENEFITS OF PHARMACOGENOMICS 38

TABLE 18 PHARMACOGENOMICS TESTS IN USE 39

BARRIERS TO PHARMACOGENOMICS PROGRESS 39

BIOMARKERS IN DRUG LABELS 39

CLASSIFICATION OF BIOMARKERS 40

TABLE 19 BIOMARKERS FOR DRUG LABELS BASED ON SPECIFIC USE 40

TABLE 20 CANCER BIOMARKERS FOR FDA-MANDATED TESTING PRIOR TO DRUG USE 40

TABLE 21 CLINICALLY RELEVANT BIOMARKERS 40

FDA GUIDANCE 41

TABLE 22 APPROVED COMPANION DIAGNOSTICS, 2011 41

COMPANION DIAGNOSTICS AND SEVERAL REGULATORY ISSUES 43

TABLE 23 REGULATORY APPROVAL OF THE DIAGNOSTICS PATHWAY 44

FDA ROUTE 44

CLIA-BASED (LABORATORY-DEVELOPED TESTS) ROUTE 44

CHOOSING A REGULATORY PATHWAY 45

A CO-DEVELOPMENT PATH 45

ISSUES AND BARRIERS TO DEVELOPMENT 46

DRUG APPROVAL IN 2011 46

TABLE 24 APPROVED CANCER DRUGS, 2011 47

POST-LAUNCH EXPECTATIONS 47

DAKO'S EGFR IMMUNOHISTOCHEMISTRY ASSAY 47

ROLE OF REIMBURSEMENT BODIES 48

CONSIDERATIONS FOR NEW DRUG–DIAGNOSTIC PARTNERSHIPS 48

TABLE 25 FACTORS INFLUENCING THE
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others
2. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Cad Software
3. Financier Jeffrey Epstein And Mount Sinai Hospital Support 3D Mammograms For Breast Cancer
4. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
5. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Volpara Breast Density Software
6. BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
7. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
8. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
9. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
10. Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession
11. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015  ArmaGen, Inc., a privately ... to treat severe neurological disorders, announced today that ... multi-center Phase 1/2a clinical trial of AGT-181 in ... AGT-181 is an investigational enzyme ... I. The most severe form of MPS I, ...
(Date:9/2/2015)... Pa. , Sept. 2, 2015 Unilife ... and ASX: UNS), a developer, manufacturer and supplier of ... to third-party initiated expressions of interest, the Company,s Board ... to conduct a review of strategic alternatives to maximize ... be explored and evaluated during the review process may ...
(Date:9/2/2015)... PUNE, India , September 2, 2015 ... "Veterinary Imaging Market by Product (Digital & Computed Radiography, ... SPECT, Interventional Radiology, PACS) by Application (Oncology, Cardiology, Neurology) ... Market Is Poised to reach USD 2.8 Billion by ... forecasted period. Br owse 240 ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Unilife Announces Review of Strategic Alternatives 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5
(Date:9/2/2015)... ... ... article published August 12 by International Business Times, a new bill was signed ... in cases meant to decide if a police officer used deadly or excessive force in ... and New York City that absolved police officers of charges in the deaths of two ...
(Date:9/2/2015)... ... September 02, 2015 , ... Specifically, ... the news recently following a decision by the Centers for Medicare & Medicaid ... to average approximately $71,000 or roughly 40% of its headline-grabbing $178,000 price tag. ...
(Date:9/2/2015)... ... September 02, 2015 , ... RxNT , an ... of its enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone ... usability. A leader in health technology, RxNT was one of the first to ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... 2015 , ... A UPMC and University of Pittsburgh Schools ... a premier center for treatment of and research into hereditary hemorrhagic telangiectasia (HHT), ... , Cure HHT, previously known as The HHT Foundation International, has designated ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4
... BEIJING, June 26 /PRNewswire-Asia/ -- RainEarth Inc.,(OTC Bulletin ... China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"),has obtained ... that aid in manufacturing blood dialysis. , ... for patents for its core,technology with the State Intellectual ...
... HOUSTON, June 26 The Breast Center at Houston Northwest ... the United States -- and one in Texas -- to ... by the National Quality Measures for Breast Centers (NQMBC) Program(TM). ... measure performance of interdisciplinary breast care nationwide. The designation is ...
... ... in Omaha list for the second straight year. The list is sponsored by the Greater Omaha ... an Omaha business. , ... June 26, 2009 -- Healthcare staffing company Medical Solutions has landed on the ...
... DC (26 June, 2009) Combating high blood pressure ... enjoyed reductions in cardiovascular disease over recent decades, Latin ... published in the journal Therapeutic Advances in Cardiovascular ... the increase in many Latin American countries, a situation ...
... Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ... the Food and Drug Administration, today arrived and seized ... also included ingredients held at these same facilities. The ... in May 2009, found unresolved violations of cGMP requirements ...
... Texas, June 25 Torchmark Corporation (NYSE: TMK ... $300 million in aggregate principal amount of 9.25% Senior Notes ... to close on June 30, 2009, subject to the satisfaction ... offering will be used for the repayment of the $99.45 ...
Cached Medicine News:Health News:RainEarth Obtains Patent Approvals for Its Core Technology 2Health News:RainEarth Obtains Patent Approvals for Its Core Technology 3Health News:The Breast Center at Houston Northwest Medical Center Receives Prestigious National Award 2Health News:The Breast Center at Houston Northwest Medical Center Receives Prestigious National Award 3Health News:Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha" 2Health News:Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha" 3Health News:Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha" 4Health News:Latin America must cut blood pressure to thrive 2Health News:Latin America must cut blood pressure to thrive 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action 2Health News:Torchmark Prices Senior Notes Offering 2
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....
Medicine Products: